Department of Medicine

January 4, 2024

Study shows liraglutide results in increased insulin sensitivity independent of weight loss

By Jill Clendening
January 4, 2024

Potential AML therapy induces leukemic stem cell death

Vanderbilt researchers are studying a potential therapy for acute myeloid leukemia that targets the residual leukemic stem cells in bone marrow after treatment that are responsible for relapses and drug resistance.

By Tom Wilemon
December 29, 2023

VUMC to launch Program for Health Equity Research

VUMC’s new Program for Health Equity Research aims to become the nation’s leader in health equity research that’s inclusive, supportive and diverse by creating a rigorous environment for application-driven research with rapid response to policies and practices.

By Kathy Whitney
December 20, 2023

Appointments, additions in 2023 strengthen VUMC’s core missions

During the past year, multiple new appointments and additions strengthened VUMC’s core missions.

By VUMC News and Communications
December 19, 2023

Melanoma, anyone?

Collegiate tennis and golf athletes aren’t using enough sunscreen according to a recent survey; meanwhile, the deadly skin cancer melanoma is on the rise.

By Paul Govern
December 19, 2023

Three from VUMC elected to ASCI

Three physician scientists from Vanderbilt University Medical Center have been elected this year to membership in the American Society for Clinical Investigation, one of the nation’s oldest and most respected medical honor societies.

By Bill Snyder
December 15, 2023

Clinical trial shows efficacy for atezolizumab combined with carboplatin

By Tom Wilemon
December 11, 2023

Colorectal cancer ‘cartography’ reveals an avenue to improved immunotherapy

Vanderbilt University Medical Center researchers have discovered why most colorectal tumors escape detection and destruction by the body’s immune system.
By Bill Snyder
December 8, 2023

Vanderbilt research presented at Cancer Moonshot meet

Vanderbilt Colorectal cancer expert Bob Coffey, MD, was recently invited to present his research to representatives of President Joe Biden’s reignited Cancer Moonshot initiative.
By Bill Snyder
December 8, 2023

You missed a few: a better way to count health care-associated influenza cases

The traditional definition of health care-associated influenza leads to gross undercounting, a Vanderbilt study suggests.
By Paul Govern
December 5, 2023

Role of immunity in kidney injury hints at a potential therapy: study

Targeting the cytokine IL-22 could be a new therapeutic approach to prevent kidney injury caused by drugs or toxins, Vanderbilt researchers have discovered.
By Bill Snyder
December 5, 2023

Eden Biltibo is Multiple Myeloma Research Foundation scholar recipient

Vanderbilt’s Eden Biltibo, MD, MS, is one of the first recipients of the Multiple Myeloma Research Foundation’s Scholars Program, an initiative launched in 2022.
By Tom Wilemon
December 4, 2023

New study uses genetic data to support use of thiazide diuretics for kidney stone prevention

A Vanderbilt University Medical Center genetic association study of more than 1 million adults supports the use of the common blood thinner medication thiazide diuretics for kidney stone prevention.
By Danny Bonvissuto
1 … 3 4 5 6 7 … 102